THEDES as a drug product intermediate for improved melt-extrusion processibility of thermally labile active ingredients

Research output: Contribution to journalArticlepeer-review

31 Downloads (Pure)

Abstract

Hot melt extrusion (HME) is extensively employed in the pharmaceutical industry, but its utilization of heat raises concerns over drugs’ thermal stability. Strategies to improve stability and processibility of thermolabile materials via salt formation and co-crystals engineering are found in the literature. In this work, it was attempted to use therapeutic deep eutectic solvents (THEDES) as a mean to achieve improved drug thermal stability through the formation of a charge-assisted strong hydrogen boding network. Thermogravimetric studies on THEDES formed using a thermolabile drug, lidocaine, with different non-steroidal anti-inflammatory agents (NSAIDs) were employed to test this hypothesis. The resulted three THEDESs in this study were all tested to be more thermally stable than the corresponding parent compounds, confirming the stabilizing effect from the THEDES bonding network. This investigation reintroduces THEDES as a drug product intermediate with improved processibility for HME.  
Original languageEnglish
Article number1342
Pages (from-to)S1-S2
JournalBritish Journal of Pharmacy
Volume8
Issue number2
DOIs
Publication statusPublished - 30 Dec 2023
Event14th APS International PharmSci 2023 - Reading, United Kingdom
Duration: 05 Sept 202307 Sept 2023

Keywords

  • General Medicine

Fingerprint

Dive into the research topics of 'THEDES as a drug product intermediate for improved melt-extrusion processibility of thermally labile active ingredients'. Together they form a unique fingerprint.

Cite this